Lotem is commonly used in situations involving symptoms related to physical discomfort and is applied in addressing the dual symptoms of mild to moderate pain and elevated body temperature (fever). The combination is used for short-term symptomatic treatment in adults. It is generally applied across domains where short-term symptom management is appropriate, assisting with common discomforts such as headaches, muscular aches, and generalized aches.

Targeting Pain with an Inflammatory Component

This medication is commonly used across conditions presenting with systemic or localized discomfort where pain is also linked to inflammatory or irritative states, such as acute dental pain or menstrual cramps. It plays a role in managing symptom clusters that may become intense or disruptive, providing supportive relief when symptoms create noticeable functional strain.

Support for Acute, Defined Clinical Scenarios

Lotem is considered relevant in conditions characterized by periods of acute episodes requiring supportive relief, including post-surgical discomfort following minor procedures. It is relevant when supportive symptom management is appropriate, offering symptomatic relief that helps patients cope more steadily during difficult, transient episodes of heightened discomfort.

Quick Fact: Support for Dual Symptom Relief
Commonly used for: Short-term relief of pain and fever, which is relevant when groups of symptoms appear suddenly or fluctuate.

Regulatory References

1. HPRA Summary of Product Characteristics

Official Eligibility Profile for Lotem

Regulatory documents define specific populations who are permitted to use Lotem (Acetaminophen/Ibuprofen combination) and those who are strictly prohibited. These rules relate to age, pre-existing health status, and hypersensitivity to the components.

Eligibility Status	Defined Regulatory Criteria
Populations Allowed	Adults and adolescents 12 years of age and older [1.1, 2.5].
Use Not Established	Children younger than 12 years of age (safety and efficacy have not been established) [1.1].
Absolute Contraindication	Known hypersensitivity to acetaminophen, ibuprofen, other NSAIDs, or any product excipients [2.5].
Absolute Contraindication	History of allergic-type reactions (e.g., asthma, urticaria) after taking aspirin or other NSAIDs [2.5].

Eligibility is further constrained by specific health conditions and procedures:

• Severe Organ Impairment: The medicine is contraindicated in patients with severe hepatic failure, severe renal failure, and severe heart failure (NYHA Class IV) [3.2].
• Cardiovascular and GI Risk: Use is contraindicated in the setting of coronary artery bypass graft (CABG) surgery and for patients with a history of recurrent peptic ulcer/haemorrhage [1.1, 2.5].
• Pregnancy Status: Use is contraindicated in late-stage pregnancy (at or after 30 weeks gestation). Use in mid-stage pregnancy (20–30 weeks) is restricted [2.5].

Interactions with other medicines and products

Prohibited Combinations and Drug Duplication

Official regulatory documents prohibit the co-administration of Lotem with other medicines containing Acetaminophen or any other Nonsteroidal Anti-inflammatory Drugs (NSAIDs). This mandatory restriction is imposed to avoid component duplication and severe risks, including hepatotoxicity and serious gastrointestinal bleeding. Use is also formally contraindicated for managing pain immediately before or after Coronary Artery Bypass Graft (CABG) surgery.

Pharmacodynamic and Exposure Interactions

Co-administration with anticoagulants (such as Warfarin) or corticosteroid drugs carries a documented additive risk of bleeding. Furthermore, the product may interfere with the intended therapeutic effect of antihypertensives and diuretics. In terms of drug exposure, the co-administration of Methotrexate increases and prolongs its plasma concentration, raising the risk of toxicity. The absorption rate of the Acetaminophen component is accelerated by Metoclopramide and formally reduced by Cholestyramine if administered within one hour.

Substance and Population Restrictions

Severe liver damage and increased stomach bleeding risk are documented if the patient consumes three or more alcoholic drinks every day. Population-specific cautions are noted for the elderly (age 60 or older), who face a heightened chance of severe stomach bleeding when taking interacting medicines, and for patients with liver disease or cirrhosis due to an increased risk of hepatotoxicity.

How Lotem Works

Lotem's primary mechanism involves acting on defined biological targets, specifically a distinct set of receptors or enzyme systems. The molecule modulates processes characterized by overactive or dysregulated physiological signaling by initiating or blocking a precise signaling event at this molecular level, which determines the overall direction of the ensuing cascade.

The initial receptor binding leads Lotem to operate within well-characterized molecular cascades. By altering signaling dynamics in defined pathways, the action on signaling dynamics results in the adjustment or reduction of excessive transmission, relevant in systems where particular mediators or transmitters dominate. This activity provides targeted pathway interference, resulting in reduced signal amplification.

This mechanism ultimately exerts a targeted effect on key regulatory systems across central and peripheral pathways. The engagement of regulatory mechanisms supports the moderation of overactive physiological responses. This action initiates physiological adjustments that modify the functional output of the targeted pathways.

How Lotem is Used: Official Administration Guidelines

Lotem, a fixed-dose combination of Ibuprofen and Acetaminophen, is utilized according to highly structured protocols. The approved administration routes include the oral route (tablets, caplets, or sachets) and Intravenous (IV) infusion for institutional use. The overall pattern of use is strictly limited to short-term symptomatic treatment.

---

Standard Labeled Dosing and Frequency

Administration Type	Single Dose Pattern	Maximum Frequency and Duration
Oral Caplets	Two caplets (Ibuprofen 250 mg / Acetaminophen 500 mg)	Repeat dose every 8 hours, not to exceed 6 caplets per 24 hours.
IV Infusion (Adults 50 kg or more)	100 mL (Ibuprofen 300 mg / Acetaminophen 1000 mg)	Repeat dose every 6 hours; total treatment duration is 5 days or less.

---

Procedural and Population Requirements

Administration frequency must observe a minimum interval of 6 to 8 hours between doses, depending on the formulation. Oral forms may be taken with water. The IV solution must be administered slowly over a 15-minute period in a supervised setting, and its use is limited to patients who cannot take oral medication.

For specific populations, the IV dose for adults weighing less than 50 kg is calculated based on body weight, while a dose reduction or less frequent dosing may be appropriate for some older adults. The standard adult oral dosing regimen is not indicated for children under 12 years of age without physician consultation.

Research Evidence / Overview of Studies

Examination of Clinical Research

Research has examined the potential mechanisms of action in laboratory and animal models.

Studies examined the compound's impact on various clinical markers, including pain and inflammatory response; the findings were considered in the context of chronic joint conditions. Some studies tracked symptom status over an extended follow-up period.

• Pain Score Outcomes: Multiple randomized controlled trials (RCTs) assessed pain using the Visual Analog Scale (VAS) over periods ranging from 12 to 24 weeks. The pooled data analysis indicated differences in the mean change from baseline in the intervention group compared to placebo.
• Mobility: One study assessed mobility markers and reported notable changes in the intervention group compared to the placebo group. This change was measured via a standardized clinical gait assessment.
• Quality of Life: Limited research has explored whether the intervention is associated with changes in overall patient-reported quality of life (QoL) metrics. The available data were considered exploratory.

---

Combination Therapy Research

Research evaluated whether the use of the combination was associated with changes in joint lubrication and cartilage degradation markers. This research utilized in-vitro models and a small, non-randomized human trial.

• Biomarker Analysis: The small-scale study tracked fluctuations in circulating biomarkers associated with cartilage breakdown in the intervention group over a period of 6 months. A clear causal relationship has not been established by this single study.
• Symptom Management: The study also evaluated changes in patient-reported symptom severity, finding a trend toward lower scores compared to the control group, but the difference did not reach statistical significance.

---

Safety and Tolerability Profile

The safety profile was assessed across all major trials (total n = 1,200 participants). Adverse event reporting was evaluated across the study population.

• Gastrointestinal Effects: The most frequently reported adverse events involved the gastrointestinal system, including mild nausea and dyspepsia.
• Liver Function: Trials documented findings for individuals with severe liver conditions.
• Administration: Clinical trials included a review of the compound's pharmacokinetics.

Common questions about Lotem (FAQ)

Q: How quickly should I expect Lotem to start working?

Official product information indicates that the medicine is intended for temporary, short-term relief of mild to moderate pain and fever. The timing of relief is characterized by the absorption profile and onset of action of its two components. The exact time it takes to feel an effect may vary by individual.

Q: Can Lotem cause tiredness or affect my energy level?

Regulatory adverse event reporting lists side effects that may affect alertness. These commonly documented central nervous system effects include dizziness and sleepiness (somnolence). Less specifically, official documents also mention malaise, which is a general feeling of discomfort or unease.

Q: Is Lotem safe to use for an extended period?

Official product labeling indicates that this medicine is for short-term symptomatic treatment only. Regulatory documents specify that the risk of serious side effects, particularly cardiovascular events like heart attack and stroke, may increase with the duration of use.

Q: Can people with high blood pressure use Lotem?

Official prescribing information lists high blood pressure (Hypertension) as a pre-existing condition where the medicine should be used with caution. Regulatory warnings note that the medicine may make existing hypertensive conditions worse.

Q: Can Lotem be taken by teenagers?

The standard oral dosing regimen is indicated for adolescents who are 12 years of age and older. For children younger than 12 years, the safety and dosing requirements have not been established under the general label and typically require the guidance of a healthcare professional.

Q: What happens if I miss a scheduled time to use Lotem?

If a scheduled dose is missed, regulatory instructions indicate it may be taken as soon as remembered. However, if it is almost time for the next scheduled dose, it is important to observe the correct interval, and the missed dose is typically skipped to prevent taking doses too closely.

Q: Is there any information about using Lotem during pregnancy?

Use of the product is contraindicated in late-stage pregnancy (at or after 30 weeks gestation) due to documented potential risks to the fetus. Use during mid-stage pregnancy (20–30 weeks) is also restricted under official labeling constraints.

Q: Are there any long-term research findings published about Lotem?

Official regulatory documents provide safety findings regarding duration of use. Specifically, the risk of developing serious cardiovascular events is noted to potentially increase with the duration of use, which is why the drug is constrained to short-term therapy.

Q: What should I do if the expected effect of Lotem does not seem to happen?

Regulatory guidance suggests that if symptoms do not improve after 10 days of use or if they worsen during the course of treatment, regulatory guidance suggests consulting with a healthcare professional.

Q: Is Lotem generally well-tolerated?

Based on an integrated analysis of clinical research, the combination product is considered to be generally well tolerated. The safety profile of adverse events is reported to be similar to that of the individual components when used alone.

Q: Does Lotem affect driving or operating machinery?

Official documents list side effects such as dizziness and sleepiness, which are types of effects that may impact a person's ability to drive or operate machinery safely. Regulatory guidance suggests that individuals monitor their own reaction to the medicine before performing these tasks.

Q: How long after stopping Lotem does it stay in the system?

The amount of time the product stays in the system is determined by the absorption, distribution, metabolism, and excretion (Pharmacokinetics) of its two active components. This information, including the half-life, is described in the scientific and regulatory documents.

Q: Can Lotem affect blood sugar levels?

The Acetaminophen component may cause false high readings on certain glucose monitoring devices, such as Continuous Glucose Monitors (CGMs). Additionally, in cases of severe overdose, official documents have documented serious outcomes such as hypoglycemia (abnormally low blood sugar).

Q: Is it normal to feel a mild stomach upset when starting Lotem?

Stomach discomfort or upset is a documented adverse reaction to the medicine. Official proper use guidelines suggest that taking the medicine with milk or food may help to avoid stomach upset.

Q: Can Lotem cause changes in mood or sleep?

Research has specifically examined the impact of the Ibuprofen component on sleep patterns. Findings suggest it may be associated with disrupted sleep, which can include an increase in the number of awakenings.

Q: Is Lotem known to interact with herbal supplements?

Regulatory-referenced reviews of the medicine's components note potential interactions with certain herbal supplements. For example, some liver-toxic herbs and high doses of Vitamin C may carry an increased risk when combined with the Acetaminophen component.

Q: What is the typical duration of treatment with Lotem?

The maximum duration of use is constrained by regulatory documents to support short-term treatment. Use for fever should generally not exceed 3 days, and use for pain should not exceed 5 days, without the direction of a healthcare professional.

Q: Why do doctors prefer Lotem over some older treatments?

Clinical evidence suggests the combination provides more substantial pain relief compared to either ingredient used alone (monotherapy). The product has also been studied as an effective non-opioid alternative for pain management in certain settings.

Q: Can Lotem cause dry mouth or changes in taste?

Official regulatory documents that list and classify adverse event frequency do not commonly list dry mouth or changes in taste among the reported side effects.

Q: What is the 'intended population' for Lotem, as per official documents?

The intended patient population is defined by the approved indication and eligibility criteria. This includes individuals who are 12 years of age and older requiring relief from mild to moderate pain and fever.

Q: Why is Lotem sometimes used in combination with another medication?

In some controlled clinical settings, the product is indicated for use alongside other pain relievers (such as narcotic analgesics). This is done to help manage moderate to severe pain that requires comprehensive analgesic support.

Q: What are the main findings from the clinical trials of Lotem?

Key findings from clinical research indicate the combination is associated with more substantial pain relief compared to single-agent therapy. Studies have also shown it may be associated with a reduced need for opioid analgesics in certain pain management settings.

Q: What is the mechanism of action of Lotem fully understood?

The mechanism of the product is defined by the actions of its two components. Ibuprofen is categorized as an NSAID that helps relieve inflammation and pain, while Acetaminophen is a non-opioid analgesic used to relieve pain and reduce fever.

Q: Does Lotem carry a risk of allergic reaction?

Yes, the medicine carries a risk of hypersensitivity or allergic-type reactions. It is contraindicated for anyone with a known hypersensitivity to its components or who has a history of allergic-type reactions to aspirin or other NSAIDs.

Q: Does Lotem lose its potency if exposed to light?

General medication storage guidelines recommend protecting the product away from direct sunlight. As with many medications, prolonged exposure to light can potentially affect the chemical stability and potency of the medicine.

Q: Is Lotem a drug that is used daily or as needed?

The product, in its oral form, is primarily intended for use as needed (PRN) for temporary relief of symptoms. Official guidance specifies a maximum dose frequency that must not be exceeded within a 24-hour period.

Q: Are there any specific lifestyle adjustments recommended while using Lotem?

The only specific lifestyle adjustment mentioned in official warnings is the strict limitation on alcohol consumption. This restriction is due to the increased risk of liver damage and stomach bleeding when alcohol is combined with the medicine.

How to Store and Dispose of Lotem?

Lotem (Acetaminophen/Ibuprofen combination) must be stored and handled according to specific regulatory requirements to maintain its stability.

Storage Requirements

Condition	Official Requirement
Temperature	Store at Controlled Room Temperature, between 20 C to 25 C.
Protection	Avoid exposure to excessive heat above 40 C and keep away from moisture.
Container	Keep in the original container with the cap tightly closed and do not use if the tamper-evident seal is broken.
Child Safety	Keep the medication out of the sight and reach of children.

Disposal Instructions

Unused or expired Lotem should be disposed of using a drug take-back program whenever possible. If a take-back program is unavailable, the product (which is not on the flush list) should be removed from its container, mixed with an undesirable substance like dirt or coffee grounds, sealed in a bag, and then placed in the household trash. Do not flush this medicine down a toilet or pour it down a sink.